Q3 FY2026 · ended Sep 30, 2026 · Revenue $25.86M, +53.1% YoY · Filed Nov 5, 2026
Avita Medical, Inc. (RCEL) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $25.9 million and a net loss of $6.2 million. Free cash flow was -$821,000. As of Sep 30, 2026 it held $10.5 million in cash and investments and $47.1 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- RCEL (Nasdaq), AVHHL (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Valencia, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1762303
- Former names
- Avita Therapeutics, Inc. (until Dec 10, 2020); Avita Medical, Ltd. (until Jun 30, 2020)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $25.9M | $21.5M | $19.1M | $17.4M | $16.9M |
| Operating income | -$2.6M | -$6.9M | -$8.8M | -$10.4M | -$9.2M |
| Net income | -$6.2M | -$7.7M | -$10.6M | -$11.6M | -$13.2M |
| Diluted EPS | -$0.20 | -$0.25 | -$0.35 | -$0.38 | -$0.46 |
| Operating cash flow | -$710,000 | -$3.5M | -$10.1M | -$5.4M | -$5.2M |
| Free cash flow | -$821,000 | -$3.6M | -$10.1M | -$6.1M | -$6.2M |
| Total assets | $46.8M | $47.8M | $51.5M | $56.4M | $63.7M |
| Total liabilities | $77.8M | $75.6M | $74.7M | $73.0M | $70.4M |
| Stockholders' equity | -$31.0M | -$27.8M | -$23.2M | -$16.6M | -$6.7M |
| Cash and investments | $10.5M | $11.1M | $14.3M | $18.2M | $23.3M |
| Total debt | $47.1M | $48.5M | $48.1M | $46.0M | $44.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 11, 2026 | Aug 5, 2026 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Aug 6, 2026 | Jun 3, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
All 378 Avita Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.